Publication

The selective peroxisome proliferator‐activated receptor gamma modulator CHS‐131 improves liver histopathology and metabolism in a mouse model of obesity and nonalcoholic steatohepatitis

Hepatology Communications 4(9):1302-1315, 2020

Perakakis P, Joshi A, Peradze N, Stefanakis K,Li G, Feigh M, Veidal SS, Rosen G, Fleming M, Mantzoros CS

Share this page

Resource Library

Related resources
Poster
Disease progression in the non-obese CDAA-HFD mouse model of advanced NASH and fibrosis
Open
Poster
Metabolic, biochemical and histological effects of semaglutide in a CDAA-HFD-induced non-obese and biopsy-confirmed rat model of NASH with progressive fibrosis and tumor development
Open
Poster
Clinical translatability of the GAN diet-induced obese and biopsy-confirmed mouse model of NASH
Open
Publication
Incretin combination therapy for the treatment of non-alcoholic steatohepatitis
Open

For further information

Contact us

Gubra

Hørsholm Kongevej 11B
2970 Hørsholm
Denmark

+45 3152 ­2650

Back To Top